New Jersey Senate Bill 1102: Requires health benefits coverage of continuous glucose monitoring system for treatment of glycogen storage disease.

New Jersey · 2026-2027 Regular Session

What it does

Requires health benefits coverage of continuous glucose monitoring system for treatment of glycogen storage disease.

Introduced in the Senate, Referred to Senate Commerce Committee (2026-01-13)